Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
95.88 CHF | -0.01% |
|
+2.89% | +12.93% |
06-24 | Foreign banks target Switzerland after UBS takeover of Credit Suisse | RE |
06-24 | NOVARTIS AG : Barclays reaffirms its Sell rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.93% | 219B | |
+55.18% | 815B | |
+45.48% | 654B | |
-6.68% | 354B | |
+22.19% | 337B | |
+10.58% | 302B | |
+17.87% | 247B | |
+2.17% | 229B | |
+9.93% | 171B | |
-3.21% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Reports Positive Results from Phase 3 Study of Investigational Chronic Kidney Disease Drug